Company intelligence / Profile preview

Yantai Dinghao Biotechnology

Ownership: Private
Development stage: Other

Overview

Shandong Dinghao Biotechnology is an active Chinese biotech/pharma manufacturer specializing in R&D, production, and sales of biotechnological products, active pharmaceutical ingredients (APIs), drug intermediates, and fine chemicals. The company operates multiple factories across China and maintains strong R&D capabilities with its own research center. It supplies key pharmaceutical intermediates globally but does not develop finished therapeutics or conduct clinical trials itself.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Many universities in ChinaLarge domestic and international pharma/chemical companies

Beyond the preview

Go deeper on Yantai Dinghao Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yantai Dinghao Biotechnology.

Explore the full profile